Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

3D spheroid culture makes stem cells better at reducing inflammation.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

MSC-derived EVs have potential as therapeutic agents but face challenges like production complexity and high costs.

The hydrogel helps heal diabetic wounds by combining antibacterial, antioxidant, and immune-boosting effects.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Drug repurposing finds new uses for old drugs quickly and cheaply.

Repurposing existing drugs can quickly and cheaply find new treatments.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.